These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 9021201)

  • 1. Inhibition of multiple phases of human immunodeficiency virus type 1 replication by a dithiane compound that attacks the conserved zinc fingers of retroviral nucleocapsid proteins.
    Rice WG; Baker DC; Schaeffer CA; Graham L; Bu M; Terpening S; Clanton D; Schultz R; Bader JP; Buckheit RW; Field L; Singh PK; Turpin JA
    Antimicrob Agents Chemother; 1997 Feb; 41(2):419-26. PubMed ID: 9021201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-HIV agents that selectively target retroviral nucleocapsid protein zinc fingers without affecting cellular zinc finger proteins.
    Huang M; Maynard A; Turpin JA; Graham L; Janini GM; Covell DG; Rice WG
    J Med Chem; 1998 Apr; 41(9):1371-81. PubMed ID: 9554870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological properties of novel pyridinioalkanoyl thiolesters (PATE) as anti-HIV-1 agents that target the viral nucleocapsid protein zinc fingers.
    Turpin JA; Song Y; Inman JK; Huang M; Wallqvist A; Maynard A; Covell DG; Rice WG; Appella E
    J Med Chem; 1999 Jan; 42(1):67-86. PubMed ID: 9888834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein zinc ejection activity of disulfide benzamides and benzisothiazolones: correlation with anti-HIV and virucidal activities.
    Tummino PJ; Harvey PJ; McQuade T; Domagala J; Gogliotti R; Sanchez J; Song Y; Hupe D
    Antimicrob Agents Chemother; 1997 Feb; 41(2):394-400. PubMed ID: 9021197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azodicarbonamide inhibits HIV-1 replication by targeting the nucleocapsid protein.
    Rice WG; Turpin JA; Huang M; Clanton D; Buckheit RW; Covell DG; Wallqvist A; McDonnell NB; DeGuzman RN; Summers MF; Zalkow L; Bader JP; Haugwitz RD; Sausville EA
    Nat Med; 1997 Mar; 3(3):341-5. PubMed ID: 9055865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of HIV-1 nucleocapsid protein P7 by pyridinioalkanoyl thioesters. Characterization of reaction products and proposed mechanism of action.
    Basrur V; Song Y; Mazur SJ; Higashimoto Y; Turpin JA; Rice WG; Inman JK; Appella E
    J Biol Chem; 2000 May; 275(20):14890-7. PubMed ID: 10809733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of HIV-1 replication by a bis-thiadiazolbenzene-1,2-diamine that chelates zinc ions from retroviral nucleocapsid zinc fingers.
    Pannecouque C; Szafarowicz B; Volkova N; Bakulev V; Dehaen W; Mély Y; Daelemans D
    Antimicrob Agents Chemother; 2010 Apr; 54(4):1461-8. PubMed ID: 20124006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mimic of HIV-1 nucleocapsid protein impairs reverse transcription and displays antiviral activity.
    Druillennec S; Dong CZ; Escaich S; Gresh N; Bousseau A; Roques BP; Fournié-Zaluski MC
    Proc Natl Acad Sci U S A; 1999 Apr; 96(9):4886-91. PubMed ID: 10220388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo antiviral activity of novel human immunodeficiency virus type 1 nucleocapsid p7 zinc finger inhibitors in a transgenic murine model.
    Schito ML; Goel A; Song Y; Inman JK; Fattah RJ; Rice WG; Turpin JA; Sher A; Appella E
    AIDS Res Hum Retroviruses; 2003 Feb; 19(2):91-101. PubMed ID: 12639244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of HIV nucleocapsid protein zinc fingers as candidates for the treatment of AIDS.
    Rice WG; Supko JG; Malspeis L; Buckheit RW; Clanton D; Bu M; Graham L; Schaeffer CA; Turpin JA; Domagala J; Gogliotti R; Bader JP; Halliday SM; Coren L; Sowder RC; Arthur LO; Henderson LE
    Science; 1995 Nov; 270(5239):1194-7. PubMed ID: 7502043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of human immunodeficiency virus type 1 zinc fingers prevent normal processing of gag precursors and result in the release of noninfectious virus particles.
    Turpin JA; Terpening SJ; Schaeffer CA; Yu G; Glover CJ; Felsted RL; Sausville EA; Rice WG
    J Virol; 1996 Sep; 70(9):6180-9. PubMed ID: 8709244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, resolution, and determination of the absolute configuration of the enantiomers of cis-4,5-dihydroxy-1,2-dithiane 1,1-dioxide, an HIV-1NCp7 inhibitor.
    Mayasundari A; Rice WG; Diminnie JB; Baker DC
    Bioorg Med Chem; 2003 Jul; 11(14):3215-9. PubMed ID: 12818684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of nucleocapsid of HIV-1 in virus assembly.
    Dawson L; Yu XF
    Virology; 1998 Nov; 251(1):141-57. PubMed ID: 9813210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental determination and calculations of redox potential descriptors of compounds directed against retroviral zinc fingers: Implications for rational drug design.
    Topol IA; McGrath C; Chertova E; Dasenbrock C; Lacourse WR; Eissenstat MA; Burt SK; Henderson LE; Casas-Finet JR
    Protein Sci; 2001 Jul; 10(7):1434-45. PubMed ID: 11420445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1H NMR structure and biological studies of the His23-->Cys mutant nucleocapsid protein of HIV-1 indicate that the conformation of the first zinc finger is critical for virus infectivity.
    Déméné H; Dong CZ; Ottmann M; Rouyez MC; Jullian N; Morellet N; Mely Y; Darlix JL; Fournié-Zaluski MC; Saragosti S
    Biochemistry; 1994 Oct; 33(39):11707-16. PubMed ID: 7918387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of HIV-1 infectivity by zinc-ejecting aromatic C-nitroso compounds.
    Rice WG; Schaeffer CA; Harten B; Villinger F; South TL; Summers MF; Henderson LE; Bess JW; Arthur LO; McDougal JS
    Nature; 1993 Feb; 361(6411):473-5. PubMed ID: 8429889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of intermediates in the oxidation of zinc fingers in human immunodeficiency virus type 1 nucleocapsid protein P7.
    Hathout Y; Fabris D; Han MS; Sowder RC; Henderson LE; Fenselau C
    Drug Metab Dispos; 1996 Dec; 24(12):1395-400. PubMed ID: 8971148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The site of antiviral action of 3-nitrosobenzamide on the infectivity process of human immunodeficiency virus in human lymphocytes.
    Rice WG; Schaeffer CA; Graham L; Bu M; McDougal JS; Orloff SL; Villinger F; Young M; Oroszlan S; Fesen MR
    Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9721-4. PubMed ID: 7692451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzamide-based thiolcarbamates: a new class of HIV-1 NCp7 inhibitors.
    Goel A; Mazur SJ; Fattah RJ; Hartman TL; Turpin JA; Huang M; Rice WG; Appella E; Inman JK
    Bioorg Med Chem Lett; 2002 Mar; 12(5):767-70. PubMed ID: 11858998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2,2'-Dithiobisbenzamides derived from alpha-, beta- and gamma-amino acids possessing anti-HIV activities: synthesis and structure-activity relationship.
    Prasad JV; Loo JA; Boyer FE; Stier MA; Gogliotti RD; Turner WJ; Harvey PJ; Kramer MR; Mack DP; Scholten JD; Gracheck SJ; Domagala JM
    Bioorg Med Chem; 1998 Oct; 6(10):1707-30. PubMed ID: 9839002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.